AAAAAA

   
Results: 1-9 |
Results: 9
SEQUENTIAL IMMUNOTYPING AND GENOTYPING OF TUMOR-CELLS IN BONE-MARROW OF CANCER-PATIENTS - A MODEL STUDY
Authors: MULLER P HEMPEL D ORUZIO D EHNLE S KOLLOCH K SCHLIMOK G
Citation: P. Muller et al., SEQUENTIAL IMMUNOTYPING AND GENOTYPING OF TUMOR-CELLS IN BONE-MARROW OF CANCER-PATIENTS - A MODEL STUDY, Cytometry, 33(4), 1998, pp. 492-497
EFFICACY OF ANTIBODY TREATMENT WITH 17 1A ON REDUCTION OF MRD AFTER COMPLETION OF HIGH-DOSE CHEMOTHERAPY WITH TRANSPLANTATION OF IN-VITRO TUMOR-CELL PURGED PBSC GRAFTS IN HIGH-RISK BREAST-CANCER PATIENTS/
Authors: HEMPEL D ORUZIO D MULLER P BEHR W BROCKMEYER C WOCHNER M EHNLE S RIETHMULLER G SCHLIMOK G
Citation: D. Hempel et al., EFFICACY OF ANTIBODY TREATMENT WITH 17 1A ON REDUCTION OF MRD AFTER COMPLETION OF HIGH-DOSE CHEMOTHERAPY WITH TRANSPLANTATION OF IN-VITRO TUMOR-CELL PURGED PBSC GRAFTS IN HIGH-RISK BREAST-CANCER PATIENTS/, European journal of cancer, 33, 1997, pp. 674-674
ADOPTIVE IMMUNOTHERAPY WITH THE MONOCLONAL-ANTIBODY (MOAB) 17 1A TO REDUCE RESIDUAL DISEASE IN BREAST-CANCER PATIENTS AFTER HIGH-DOSE CHEMOTHERAPY (HDC)/
Authors: HEMPEL D MULLER P ORUZIO D EHNLE S SCHLIMOK G
Citation: D. Hempel et al., ADOPTIVE IMMUNOTHERAPY WITH THE MONOCLONAL-ANTIBODY (MOAB) 17 1A TO REDUCE RESIDUAL DISEASE IN BREAST-CANCER PATIENTS AFTER HIGH-DOSE CHEMOTHERAPY (HDC)/, Blood, 90(10), 1997, pp. 4454-4454
USE OF MAGNETIC ACTIVATED CELL SORTING FOR DETECTION OF MINIMAL RESIDUAL TUMOR-CELLS IN BONE-MARROW OF PATIENTS WITH BREAST-CANCER
Authors: HEMPEL D MULLER P ORUZIO D EHNLE S FINKEL M SCHLIMOK G
Citation: D. Hempel et al., USE OF MAGNETIC ACTIVATED CELL SORTING FOR DETECTION OF MINIMAL RESIDUAL TUMOR-CELLS IN BONE-MARROW OF PATIENTS WITH BREAST-CANCER, Blood, 90(10), 1997, pp. 4455-4455
MINIMAL RESIDUAL DISEASE IN BONE-MARROW OF CANCER-PATIENTS - COMPARISON OF 2 DIFFERENT ANTIEPITHELIAL MONOCLONAL-ANTIBODIES (MOAB) AND CHARACTERIZATION OF EPITHELIAL-CELLS USING SEQUENTIAL IMMUNOTYPING AND GENOTYPING
Authors: MULLER P HEMPEL D ORUZIO D EHNLE S KOLLOCH K SCHLIMOK G
Citation: P. Muller et al., MINIMAL RESIDUAL DISEASE IN BONE-MARROW OF CANCER-PATIENTS - COMPARISON OF 2 DIFFERENT ANTIEPITHELIAL MONOCLONAL-ANTIBODIES (MOAB) AND CHARACTERIZATION OF EPITHELIAL-CELLS USING SEQUENTIAL IMMUNOTYPING AND GENOTYPING, Blood, 90(10), 1997, pp. 4469-4469
DETECTION OF DISSEMINATED TUMOR-CELLS IN THE LIVER OF PATIENTS WITH GASTROINTESTINAL CANCER AND CORRELATION WITH CLINICAL OUTCOME
Authors: ORUZIO D MULLER P HEMPEL D BAROWSKY G LINDEMANN F WITTE J SCHLIMOK G
Citation: D. Oruzio et al., DETECTION OF DISSEMINATED TUMOR-CELLS IN THE LIVER OF PATIENTS WITH GASTROINTESTINAL CANCER AND CORRELATION WITH CLINICAL OUTCOME, Blood, 90(10), 1997, pp. 4472-4472
EXPRESSION OF AN ANTIGEN RECOGNIZED BY C-242 MONOCLONAL, ANTIBODY ON MINIMAL RESIDUAL TUMOR-CELLS IN BONE-MARROW FROM PATIENTS WITH COLORECTAL-CANCER
Authors: ORUZIO D PANTEL K HEMPEL D LINDEMANN F WITTE J PERSSON B RIETHMULLER G SCHLIMOK G
Citation: D. Oruzio et al., EXPRESSION OF AN ANTIGEN RECOGNIZED BY C-242 MONOCLONAL, ANTIBODY ON MINIMAL RESIDUAL TUMOR-CELLS IN BONE-MARROW FROM PATIENTS WITH COLORECTAL-CANCER, Blood, 88(10), 1996, pp. 3326-3326
AUTOLOGOUS PERIPHERAL STEM-CELL TRANSPLANTATION (PBSCT) AFTER HIGH-DOSE CHEMOTHERAPY IN A PATIENT WITH SECONDARY ACUTE MYELOID-LEUKEMIA ANDWEGENERS
Authors: ORUZIO D SCHALM J HEMPEL D DANI J SCHLIMOK G
Citation: D. Oruzio et al., AUTOLOGOUS PERIPHERAL STEM-CELL TRANSPLANTATION (PBSCT) AFTER HIGH-DOSE CHEMOTHERAPY IN A PATIENT WITH SECONDARY ACUTE MYELOID-LEUKEMIA ANDWEGENERS, Blood, 88(10), 1996, pp. 3870-3870
IMMUNOMAGNETIC CELL SELECTION FOR REMOVAL AND ENHANCED DETECTION OF MRD FROM PBSC HARVEST IN BREAST-CANCER PATIENTS
Authors: HEMPEL D ORUZIO D BROCKMEYER C WOCHNER M BEHR W EHNLE S SCHLIMOK G
Citation: D. Hempel et al., IMMUNOMAGNETIC CELL SELECTION FOR REMOVAL AND ENHANCED DETECTION OF MRD FROM PBSC HARVEST IN BREAST-CANCER PATIENTS, Blood, 88(10), 1996, pp. 991-991
Risultati: 1-9 |